Krystal Biotech, Inc..
biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 38
What's happening
Earlier this month
One to three months ago
-
Insider sales of Krystal Biotech stock were disclosed to the SEC by executives.Some support2 reports
-
Krystal Biotech, Inc. focuses on genetic medicines in the US.Well supported5 reports1 development inside
-
Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.Some support2 reports
Gone quiet
No new reports in 90+ days-
Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.Some support2 reports
-
Trump pledged to unleash American oil and gas, involving Krystal Biotech, Inc.Speculative1 report
-
Krystal Biotech maintained nationwide access in the US and received VYJUVEK approval in Japan for DEB treatment.Some support4 reports
-
Krystal Biotech, Inc. and Coherus Oncology are two companies that operate within the same industry, as of June 25, 2025.Speculative1 report
-
Krystal Biotech focuses on US genetic medicines, while IREN's growth surpasses the US market average and Anthony Lewis was appointed CCO.Speculative2 reports
-
Krystal Biotech focuses on genetic medicines for high unmet needs, while Atlassian designs and develops software.Speculative1 report
-
Suma Krishnan was appointed President of Research & Development at Krystal Biotech, Inc.Speculative1 report
-
AI is changing healthcare and impacting drug discovery, involving Plus Therapeutics and Animation International.Some support2 reports
-
Krystal Biotech underperformed the market so far this year as of August 4, 2025.Some support1 report
-
BofA lowered its price target for Krystal Biotech, citing growth concerns in August 2025.Some support1 report
-
Krystal Biotech, Inc. reached out to the FDA following promising early evidence.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Krystal Biotech, Inc. this week
News at the entities that move Krystal Biotech, Inc. most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Krystal Biotech, Inc.
-
Royal Bank of Canada TransactionalRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Krystal Biotech, Inc.
-
TD Cowen TransactionalAnalyst downgraded Ag Growth International Inc. due to debt management risks.Moves Krystal Biotech, Inc.
-
Citigroup Mentioned togetherCitigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Moves Krystal Biotech, Inc.
-
Jefferies Financial Group TransactionalApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Krystal Biotech, Inc.
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves Krystal Biotech, Inc.
Connections
The 14 strongest of 38, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Suma Krishnan Structural
Suma Krishnan holds the executive role of President, Research & Development at Krystal Biotech, Inc.
-
John Charles Thomas Structural
John Charles Thomas serves as the Executive Vice President of Krystal Biotech, Inc.
-
FDA Structural
The FDA formally regulates and approves Krystal Biotech's commercial products.
-
Royal Bank of Canada Transactional
Royal Bank of Canada has increased its financial stake in Krystal Biotech, Inc. stock holdings.
-
Securities and Exchange Commission Structural
Krystal Biotech is required to file mandatory disclosures regarding share holdings and institutional investment activity with the SEC.
-
TD Cowen Transactional
TD Cowen provided a buy rating and raised the price target for Krystal Biotech.
-
Jefferies Financial Group Transactional
Jefferies Financial Group issued buy ratings and price targets for Krystal Biotech.
-
Citigroup Mentioned together
Citigroup provides analyst ratings and price targets for Krystal Biotech, functioning as a key market information source.
Show all 14 connections
-
Europe Shared context
Krystal Biotech operates and receives regulatory approvals for its products within the European market.
-
LinkedIn Mentioned together
Krystal Biotech uses LinkedIn as a platform to follow industry updates.
-
Bank of America Mentioned together
The relationship is characterized by the influence of analyst firms on stock price targets due to market coverage.
-
Pittsburgh Shared context
Krystal Biotech is headquartered in Pittsburgh.
-
MarketBeat Mentioned together
MarketBeat reports consensus ratings and analysis regarding Krystal Biotech.
-
Nasdaq Shared context
Krystal Biotech, Inc. is listed and trades its stock on the Nasdaq exchange.
History
Events by the month they beganSeptember 2026
2 eventsJuly 2026
1 eventShow 1 earlier month
June 2026
12 events- Krystal Biotech, Inc. focuses on genetic medicines in the US.
- Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
- Trump pledged to unleash American oil and gas, involving Krystal Biotech, Inc.
- Krystal Biotech maintained nationwide access in the US and received VYJUVEK approval in Japan for DEB treatment.
- Krystal Biotech, Inc. and Coherus Oncology are two companies that operate within the same industry, as of June 25, 2025.
- Krystal Biotech focuses on US genetic medicines, while IREN's growth surpasses the US market average and Anthony Lewis was appointed CCO.
- Krystal Biotech focuses on genetic medicines for high unmet needs, while Atlassian designs and develops software.
- Suma Krishnan was appointed President of Research & Development at Krystal Biotech, Inc.
- AI is changing healthcare and impacting drug discovery, involving Plus Therapeutics and Animation International.
- Krystal Biotech underperformed the market so far this year as of August 4, 2025.
- BofA lowered its price target for Krystal Biotech, citing growth concerns in August 2025.
- Krystal Biotech, Inc. reached out to the FDA following promising early evidence.